Related Experiment Video
Updated: Jun 7, 2026
09:00
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
Chronic beryllium disease: an updated model interaction between innate and acquired immunity
Richard T Sawyer1, Lisa A Maier
1Asthma, Allergy and Inflammation Branch, Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Disease, National Institutes of Health, 6610 Rockledge Drive, Bethesda, MD, USA.
Summary
Beryllium exposure can cause chronic beryllium disease (CBD), an occupational lung disorder. New research proposes a hypothesis explaining how beryllium drives inflammation and granuloma formation, leading to lung function decline in CBD patients.
Area of Science:
- Immunology
- Occupational Health
- Pulmonology
Background:
- Workplace beryllium (Be) exposure is linked to chronic beryllium disease (CBD), an occupational lung disorder.
- Despite efforts to reduce exposure, millions remain at risk in the U.S.
- Previous work proposed CBD as a model for innate and acquired immunity interaction.
Purpose of the Study:
- To provide an update on the understanding of chronic beryllium disease (CBD) pathogenesis.
- To present a new hypothesis on how beryllium drives sustained inflammation and granuloma formation in CBD.
- To explore the implications of this paradigm for immune-mediated lung diseases.
Main Methods:
- Review of recent scientific findings on beryllium exposure and CBD.
- Synthesis of current knowledge to formulate a new etiological hypothesis.
- Analysis of the immune response to beryllium and its role in lung disease.
Main Results:
- A novel hypothesis is proposed for beryllium-induced chronic inflammation and granuloma formation in CBD.
- This paradigm explains progressive lung function compromise in CBD patients.
- The findings have broader implications for understanding immune-mediated lung diseases.
Conclusions:
- The new hypothesis offers a framework for understanding CBD pathogenesis.
- This research advances knowledge of beryllium's role in immune-mediated lung conditions.
- The proposed mechanism may apply to other lung diseases with immune involvement.
More Related Videos
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...